We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.39%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$335B
AUM Growth
+$21B
(+6.7%)
Cap. Flow
-$4B
Cap. Flow
% of AUM
-1.19%
Top 10 Holdings %
Top 10 Hldgs %
21.52%
Holding
3,670
New
323
Increased
1,420
Reduced
1,524
Closed
323
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$512M |
| 2 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$435M |
| 3 |
NVIDIA
NVDA
|
+$395M |
| 4 |
Carrier Global
CARR
|
+$321M |
| 5 |
Amazon
AMZN
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.66B |
| 2 |
Alibaba
BABA
|
+$881M |
| 3 |
Intel
INTC
|
+$783M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$783M |
| 5 |
Linde
LIN
|
+$667M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.8% |
| 2 | Financials | 13% |
| 3 | Consumer Discretionary | 12.7% |
| 4 | Healthcare | 12.61% |
| 5 | Communication Services | 10.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Q32 Bio
QTTB
$464M
| $1.76M | ﹤0.01% |
13,417
+5,722
| +74% | +$714K |
|
|
KLRS
2752
Kalaris Therapeutics
KLRS
$96.8M
| $1.75M | ﹤0.01% |
3,857
-479
| -11% | -$247K |
|
2753
SIGA Technologies
SIGA
$219M
| $1.75M | ﹤0.01% |
278,155
+54,728
| +24% | +$376K |
|
2754
OneWater Marine
ONEW
$201M
| $1.75M | ﹤0.01% |
41,501
-1,093
| -3% | -$50.7K |
|
|
CPLG
2755
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
| $1.75M | ﹤0.01% |
163,080
-11,986
| -7% | -$120K |
|
|
CASA
2756
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $1.74M | ﹤0.01% |
196,310
-38,925
| -17% | -$345K |
|
2757
Cadiz
CDZI
$291M
| $1.74M | ﹤0.01% |
127,960
+16,478
| +15% | +$197K |
|
2758
ImmunityBio
IBRX
$8.1B
| $1.73M | ﹤0.01% |
+577,900
| New | +$9.55M |
|
2759
Enel Chile
ENIC
$6.28B
| $1.73M | ﹤0.01% |
586,190
-1,000
| -0.2% | -$3.38K |
|
2760
ARS Pharmaceuticals
SPRY
$612M
| $1.73M | ﹤0.01% |
55,991
+5,741
| +11% | +$184K |
|
2761
Daily Journal
DJCO
$778M
| $1.73M | ﹤0.01% |
5,105
+1,011
| +25% | +$325K |
|
2762
Taysha Gene Therapies
TSHA
$1.89B
| $1.71M | ﹤0.01% |
80,422
+62,821
| +357% | +$1.45M |
|
2763
Viking Therapeutics
VKTX
$4B
| $1.7M | ﹤0.01% |
283,548
-13,210
| -4% | -$78.4K |
|
2764
Avita Medical
RCEL
$240M
| $1.69M | ﹤0.01% |
+82,167
| New | +$1.62M |
|
2765
Citius Pharmaceuticals
CTXR
$18.7M
| $1.69M | ﹤0.01% |
+19,368
| New | +$1.16M |
|
|
EGLE
2766
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $1.68M | ﹤0.01% |
+35,410
| New | +$1.61M |
|
|
VIRX
2767
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $1.68M | ﹤0.01% |
+147,734
| New | +$1.48M |
|
2768
MeiraGTx Holdings
MGTX
$1.21B
| $1.67M | ﹤0.01% |
107,890
+16,181
| +18% | +$231K |
|
2769
China Yuchai International
CYD
$1.78B
| $1.66M | ﹤0.01% |
103,694
-6,409
| -6% | -$104K |
|
2770
Omega Flex
OFLX
$312M
| $1.66M | ﹤0.01% |
11,332
-590
| -5% | -$89.1K |
|
2771
Business First Bancshares
BFST
$1.03B
| $1.65M | ﹤0.01% |
72,068
-4,129
| -5% | -$97.8K |
|
|
ZYXI
2772
DELISTED
Zynex
ZYXI
| $1.65M | ﹤0.01% |
117,024
+39,286
| +51% | +$543K |
|
2773
Merchants Bancorp
MBIN
$2.49B
| $1.65M | ﹤0.01% |
63,123
-20,661
| -25% | -$573K |
|
2774
SiriusPoint
SPNT
$2.68B
| $1.65M | ﹤0.01% |
726,835
-47,105
| -6% | -$494K |
|
2775
Adecoagro
AGRO
$1.36B
| $1.64M | ﹤0.01% |
163,639
-23,042
| -12% | -$229K |
|
Similar funds
VFT
Nuveen's Q2 2021 Portfolio in Review
As of Q2 2021, Nuveen held 3,670 positions worth $335B, up 6.7% from $314B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Nuveen's Q2 2021 filing shows 323 new, 1,420 increased, 1,524 reduced and 323 closed positions. Its largest new stake was UiPath: 2,457,331 shares worth $167M. The largest sale was Apple, an estimated $1.66B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Nuveen's largest Q2 2021 buy was UiPath: 2,457,331 shares worth $167M.
- Nuveen added most to Wells Fargo in Q2 2021, an estimated $512M increase.
- Nuveen's biggest Q2 2021 reduction was Apple, cutting an estimated $1.66B.
- Nuveen fully exited SolarEdge in Q2 2021, selling an estimated $66M.
- Nuveen's ten largest holdings make up 22% of its $335B portfolio in Q2 2021.
- Nuveen opened 323 new positions and closed 323 in Q2 2021.
- Nuveen's portfolio value rose 6.7% quarter-over-quarter to $335B.
Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.